Robeco Institutional Asset Management B.V. Has $7.01 Million Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Robeco Institutional Asset Management B.V. cut its position in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 52.1% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 20,299 shares of the company's stock after selling 22,076 shares during the quarter. Robeco Institutional Asset Management B.V.'s holdings in HCA Healthcare were worth $7,014,000 at the end of the most recent reporting period.

Other large investors have also bought and sold shares of the company. Atwood & Palmer Inc. acquired a new stake in HCA Healthcare in the first quarter worth $28,000. Whipplewood Advisors LLC acquired a new stake in HCA Healthcare in the fourth quarter worth $31,000. Tidemark LLC acquired a new stake in HCA Healthcare in the fourth quarter worth $36,000. ORG Partners LLC grew its holdings in shares of HCA Healthcare by 344.0% during the first quarter. ORG Partners LLC now owns 111 shares of the company's stock valued at $38,000 after buying an additional 86 shares during the last quarter. Finally, Legacy Investment Solutions LLC grew its holdings in shares of HCA Healthcare by 99.0% during the fourth quarter. Legacy Investment Solutions LLC now owns 191 shares of the company's stock valued at $62,000 after buying an additional 95 shares during the last quarter. 62.73% of the stock is currently owned by institutional investors and hedge funds.

HCA Healthcare Stock Up 0.4%

Shares of NYSE HCA opened at $379.00 on Monday. The company has a current ratio of 1.19, a quick ratio of 1.06 and a debt-to-equity ratio of 69.07. HCA Healthcare, Inc. has a 12 month low of $289.98 and a 12 month high of $417.14. The firm has a market capitalization of $91.18 billion, a PE ratio of 16.85, a price-to-earnings-growth ratio of 1.31 and a beta of 1.49. The firm has a fifty day simple moving average of $366.55 and a two-hundred day simple moving average of $337.09.

HCA Healthcare (NYSE:HCA - Get Free Report) last issued its quarterly earnings results on Friday, April 25th. The company reported $6.45 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.75 by $0.70. The company had revenue of $18.32 billion during the quarter, compared to analyst estimates of $18.26 billion. HCA Healthcare had a net margin of 8.07% and a return on equity of 1,063.91%. HCA Healthcare's quarterly revenue was up 5.7% compared to the same quarter last year. During the same period last year, the business earned $5.36 EPS. Equities analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, June 30th. Stockholders of record on Monday, June 16th will be issued a dividend of $0.72 per share. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.76%. The ex-dividend date of this dividend is Monday, June 16th. HCA Healthcare's payout ratio is presently 12.81%.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on the stock. Morgan Stanley set a $410.00 price target on shares of HCA Healthcare and gave the company an "equal weight" rating in a research report on Monday, June 9th. Wells Fargo & Company raised shares of HCA Healthcare from an "underweight" rating to an "equal weight" rating and lifted their price objective for the stock from $320.00 to $385.00 in a research report on Thursday, May 29th. Wall Street Zen lowered shares of HCA Healthcare from a "buy" rating to a "hold" rating in a research report on Friday. Robert W. Baird reaffirmed a "neutral" rating and issued a $336.00 price objective (down previously from $396.00) on shares of HCA Healthcare in a research report on Tuesday, April 15th. Finally, Royal Bank Of Canada restated an "outperform" rating and set a $404.00 price target (up from $376.00) on shares of HCA Healthcare in a research note on Monday, June 23rd. Eight investment analysts have rated the stock with a hold rating, ten have given a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus target price of $395.71.

Insider Activity

In related news, COO Jon M. Foster sold 15,698 shares of the firm's stock in a transaction that occurred on Tuesday, May 13th. The shares were sold at an average price of $369.32, for a total value of $5,797,585.36. Following the transaction, the chief operating officer now owns 12,646 shares of the company's stock, valued at approximately $4,670,420.72. This trade represents a 55.38% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Insiders own 1.30% of the company's stock.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.